These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 11535503

  • 1. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H.
    Dearden CE, Matutes E, Cazin B, Tjønnfjord GE, Parreira A, Nomdedeu B, Leoni P, Clark FJ, Radia D, Rassam SM, Roques T, Ketterer N, Brito-Babapulle V, Dyer MJ, Catovsky D.
    Blood; 2001 Sep 15; 98(6):1721-6. PubMed ID: 11535503
    [Abstract] [Full Text] [Related]

  • 2. Treatment of T-cell prolymphocytic leukemia with human CD52 antibody.
    Pawson R, Dyer MJ, Barge R, Matutes E, Thornton PD, Emmett E, Kluin-Nelemans JC, Fibbe WE, Willemze R, Catovsky D.
    J Clin Oncol; 1997 Jul 15; 15(7):2667-72. PubMed ID: 9215839
    [Abstract] [Full Text] [Related]

  • 3. Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders.
    Pangalis GA, Dimopoulou MN, Angelopoulou MK, Tsekouras C, Vassilakopoulos TP, Vaiopoulos G, Siakantaris MP.
    Med Oncol; 2001 Jul 15; 18(2):99-107. PubMed ID: 11778765
    [Abstract] [Full Text] [Related]

  • 4. Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed.
    Keating MJ, Cazin B, Coutré S, Birhiray R, Kovacsovics T, Langer W, Leber B, Maughan T, Rai K, Tjønnfjord G, Bekradda M, Itzhaki M, Hérait P.
    J Clin Oncol; 2002 Jan 01; 20(1):205-13. PubMed ID: 11773171
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alemtuzumab in peripheral T-cell malignancies.
    Dearden C.
    Cancer Biother Radiopharm; 2004 Aug 01; 19(4):391-8. PubMed ID: 15453953
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Patterns of Late Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with T-Cell Prolymphocytic Leukemia.
    Shumilov E, Hasenkamp J, Szuszies CJ, Koch R, Wulf GG.
    Acta Haematol; 2021 Aug 01; 144(1):105-110. PubMed ID: 32259827
    [Abstract] [Full Text] [Related]

  • 12. T-cell prolymphocytic leukemia: update and focus on alemtuzumab (Campath-1H).
    Cao TM, Coutre SE.
    Hematology; 2003 Feb 01; 8(1):1-6. PubMed ID: 12623420
    [Abstract] [Full Text] [Related]

  • 13. Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.
    Rai KR, Freter CE, Mercier RJ, Cooper MR, Mitchell BS, Stadtmauer EA, Santábarbara P, Wacker B, Brettman L.
    J Clin Oncol; 2002 Sep 15; 20(18):3891-7. PubMed ID: 12228210
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. How I treat prolymphocytic leukemia.
    Dearden C.
    Blood; 2012 Jul 19; 120(3):538-51. PubMed ID: 22649104
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.
    Lundin J, Osterborg A, Brittinger G, Crowther D, Dombret H, Engert A, Epenetos A, Gisselbrecht C, Huhn D, Jaeger U, Thomas J, Marcus R, Nissen N, Poynton C, Rankin E, Stahel R, Uppenkamp M, Willemze R, Mellstedt H.
    J Clin Oncol; 1998 Oct 19; 16(10):3257-63. PubMed ID: 9779699
    [Abstract] [Full Text] [Related]

  • 20. Complete response to alemtuzumab in a patient with B prolymphocytic leukemia.
    Chaar BT, Petruska PJ.
    Am J Hematol; 2007 May 19; 82(5):417. PubMed ID: 17160995
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.